Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis (2022)
Attributed to:
Investigation into the role of ceramide in the pathogenesis of cystic fibrosis lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcf.2022.06.003
PubMed Identifier: 35718668
Publication URI: http://europepmc.org/abstract/MED/35718668
Type: Journal Article/Review
Parent Publication: Journal of Cystic Fibrosis
Issue: 5
ISSN: 1569-1993